1h Free Analyst Time
The publisher has been monitoring the topical drugs market and it is poised to grow by $70.95 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. The report on the topical drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of skin diseases, the growth of the geriatric population, and product launches.
The topical drugs market analysis includes product segment and geographic landscape.
The topical drugs market is segmented as below:
By Product
- Semi-solid
- Liquid
- Solid
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the use of 3D printing technology as one of the prime reasons driving the topical drugs market growth during the next few years. Also, technological advances in the topical drug delivery system and a strong pipeline will lead to sizable demand in the market.
The report on the topical drugs market covers the following areas:
- Topical drugs market sizing
- Topical drugs market forecast
- Topical drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading topical drugs market vendors that include 3M Corp., AbbVie Inc., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., CMP Pharma Inc., Crescita Therapeutics Inc., GlaxoSmithKline Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson, and Johnson, MedPharm Ltd., Nestle SA, Pfizer Inc., Sheffield Pharmaceuticals LLC, Sol-Gel Technologies Ltd., Sun Pharmaceutical Industries Ltd., Teligent Inc., and Viatris Inc. Also, the topical drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global topical drugs market: 3M Corp., AbbVie Inc., Bausch Health Companies Inc., Bayer AG, Cipla Ltd., CMP Pharma Inc., Crescita Therapeutics Inc., GlaxoSmithKline Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson, and Johnson, MedPharm Ltd., Nestle SA, Pfizer Inc., Sheffield Pharmaceuticals LLC, Sol-Gel Technologies Ltd., Sun Pharmaceutical Industries Ltd., Teligent Inc., and Viatris Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the use of the 3d printing technology."
According to the report, one of the major drivers for this market is the increase in the prevalence of skin diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Corp.
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Cipla Ltd.
- CMP Pharma Inc.
- Crescita Therapeutics Inc.
- GlaxoSmithKline Plc
- Hisamitsu Pharmaceutical Co. Inc.
- Johnson and Johnson
- MedPharm Ltd.
- Nestle SA
- Pfizer Inc.
- Sheffield Pharmaceuticals LLC
- Sol-Gel Technologies Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teligent Inc.
- Viatris Inc.